[Experimental study on differentiation of adult marrow mesenchymal stem cells into vascular endothelial cells in

Kaili Yan1, Jian Wang, Qing Li

  • 1Department of Central Experimental Laboratory, Anhui Provincial Hospital, Hefei Anhui, 230000, P. R. China.

Abstract

Insights

Adult mesenchymal stem cells (MSCs) can become vascular endothelial cells. Optimal differentiation occurred with vascular endothelial growth factor (VEGF) and bovine pituitary extract at high cell densities, suggesting MSCs for tissue engineering.

Area of Science:

  • Stem Cell Biology
  • Vascular Biology
  • Tissue Engineering

Background:

  • Mesenchymal stem cells (MSCs) are multipotent stromal cells with regenerative potential.
  • Vascular endothelial cells form the inner lining of blood vessels and are crucial for angiogenesis.
  • Generating vascular endothelial cells from MSCs could advance regenerative medicine.

Purpose of the Study:

  • To investigate the differentiation of adult bone marrow MSCs into vascular endothelial cells in vitro.
  • To identify optimal conditions for inducing this differentiation process.

Main Methods:

  • MSCs were isolated and cultured.
  • Cells were induced to differentiate using vascular endothelial growth factor (VEGF) and bovine pituitary extract under varying cell densities and serum concentrations.
  • Differentiation was assessed by surface marker expression (CD34, VEGFR-2, CD31, vWF) and in vitro angiogenesis assays.

Main Results:

  • Group 3 cells (high density, low serum) expressed vascular endothelial cell markers (CD34, VEGFR-2, CD31, vWF) by day 14, with increased VEGFR-2 and CD34 expression by day 21.
  • These induced cells exhibited low proliferation and formed capillary-like structures.
  • Other experimental groups did not show significant differentiation.

Conclusions:

  • Adult MSCs can differentiate into vascular endothelial cells under specific inducing conditions.
  • High cell density and low proliferation conditions, combined with VEGF and bovine pituitary extract, are effective for MSC differentiation into vascular endothelial cells.
  • Adult MSCs show promise as seed cells for therapeutic neovascularization and tissue engineering applications.